UK notified bodies would have had their conformity assessment roles temporarily withdrawn in the event of a no-deal Brexit in March. Discover the implications for companies with devices that needed notifiedbody assessment before getting their CE mark. Learn what this move would have meant to UK start-ups and small companies. Find out how this decision runs directly counter to the goal of pro-Brexit policymakers. Read the MHRA response to a Medtech Insight inquiry about the role of UK notified bodies after Brexit. How would MHRA support the continuity of supply of products to the UK market?